NovoCure
NVCR
NVCR
200 hedge funds and large institutions have $3.06B invested in NovoCure in 2019 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.52% more ownership
Funds ownership: 62.39% → 66.92% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 67
Holders
200
Holding in Top 10
4
Calls
$65.4M
Puts
$11.8M
Top Buyers
| 1 | +$171M | |
| 2 | +$108M | |
| 3 | +$37.9M | |
| 4 |
D.E. Shaw & Co
New York
|
+$29.6M |
| 5 |
Two Sigma Investments
New York
|
+$22.6M |
Top Sellers
| 1 | -$36.3M | |
| 2 | -$33.1M | |
| 3 | -$22.4M | |
| 4 |
DCP
Darsana Capital Partners
New York
|
-$19.3M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$18.3M |